Mizuho analyst Ann Hynes raised the firm’s price target on CVS Health (CVS) to $88 from $76 and keeps an Outperform rating on the shares. The firm adjusted price targets in the healthcare facility and managed care space following an analysis of Medicare Advantage star ratings. The target changes are driven by increased earnings visibility on key issues along with the overall rotation into the healthcare sector, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CVS:
- Amazon (AMZN) Pharmacy Brings Prescription Kiosks to Doctors’ Offices
- CVS Health price target raised to $103 from $84 at Wells Fargo
- Looking for Exposure to UnitedHealth Stock (UNH)? Here’s How to Buy Without the Risk
- Sector Spotlight: UnitedHealth shareholder proposes split of CEO, chair role
- Trump Trade: White House announces drug pricing deal with Pfizer